The Fiber Supplement That Actually Moved LDL in 41 Clinical Trials
A 2025 meta-analysis of 41 randomized trials found psyllium modestly lowered LDL and total cholesterol, with no clear effect on triglycerides or HDL.
Quick take
- Across 41 RCTs, psyllium lowered LDL by about 8.6 mg/dL on average.
- Total cholesterol also fell, but triglycerides and HDL did not clearly change.
- Useful adjunct, not a replacement for statins, diet quality, or medical care.
The paper
- Title
- Psyllium supplementation and lipid profiles: systematic review and dose-response meta-analysis of randomized controlled trials.
- Authors
- Zeinab Gholami, Zamzam Paknahad
- Journal
- Genes & nutrition
- Published
- 2025-12-09
- DOI
- 10.1186/s12263-025-00786-5
- PMID
- 41366295
StackIQ take
Psyllium is one of the more plausible supplement-style options for cholesterol because it behaves more like a functional food fiber than a magic pill. But the size of benefit here is modest, and the big between-study variability is a reminder that real-world results depend on the rest of the diet, baseline cholesterol, and whether someone can take it consistently.
What they did
This was a systematic review and dose-response meta-analysis of 41 randomized controlled trials including 2,049 adults. The researchers looked at whether psyllium supplementation changed standard blood lipid markers: LDL cholesterol, total cholesterol, triglycerides, and HDL cholesterol.
Trials varied in dose and duration, and compared psyllium with control conditions in adults. The authors pooled the results using a random-effects model and also tested whether higher doses or longer use had a linear relationship with bigger lipid changes.
What they found
On average, psyllium significantly reduced LDL cholesterol by 8.55 mg/dL (95% CI 4.19 to 12.92 lower; p<0.001) and total cholesterol by 9.05 mg/dL (95% CI 4.40 to 13.71 lower). Those are modest but potentially meaningful changes, especially for people trying to improve cholesterol non-pharmacologically.
The pooled results did not show clear benefits for other lipid markers. Triglycerides fell by 5.29 mg/dL on average, but this was not statistically significant (95% CI 1.54 higher to 12.14 lower). HDL rose by 0.57 mg/dL on average, also not statistically significant (95% CI 0.88 lower to 2.04 higher).
The dose-response analysis did not find a significant linear relationship between psyllium dose or study duration and lipid changes. In other words, this paper did not show that simply taking more psyllium or taking it longer reliably produced larger improvements.
How good is the evidence?
This is stronger evidence than a single trial because it pools 41 randomized controlled trials, and the paper was peer-reviewed and prospectively registered in PROSPERO. Randomized trials are usually the best design for testing whether a supplement changes a lab outcome like cholesterol.
That said, the meta-analysis had substantial heterogeneity: I² was about 88% for LDL, 89% for total cholesterol, 83% for triglycerides, and 78% for HDL. That means results varied a lot across studies, likely because of differences in populations, background diets, doses, formulations, and trial quality. So the average effect is informative, but individual results may differ.
What this cannot tell us
This paper does not prove psyllium prevents heart attacks, strokes, or death. It measured lipid biomarkers, not hard cardiovascular outcomes.
It also does not show that psyllium meaningfully raises HDL or lowers triglycerides, and it does not prove that higher doses are better. The findings support psyllium mainly as a modest LDL- and total-cholesterol-lowering add-on, not a comprehensive fix for dyslipidemia.
Bottom line
If your goal is lowering LDL cholesterol, psyllium has reasonably solid evidence for a modest benefit. Just keep expectations calibrated: it may help around the margins, but it is not a substitute for overall diet quality, prescribed lipid-lowering therapy, or clinician-guided care.